Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LIPO Lipella Pharmaceuticals Inc. Common Stock
$0.18 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LIPO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 739.3K
Enterprise value -783040
Trailing PE -0.033402922009128
Forward PE -0.049999997
PEG Ratio 0.00042663138011658
Enterprise to EBITDA 0.145
Enterprise to revenue -2.009
Price to book MRQ 0.4968944
Price to sales TTM 1.8967811

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 389.8K
EBITDA -5407074
Diluted EPS TTM -2.26
Total Cash (MRQ) 1.9M
Current ratio (MRQ) 3.237
Operating Cash Flow (TTM) -4775734

LIPO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LIPO News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.